What’s the current market cap for Teleflex stock?

Teleflex (TFX) has a market cap of $5.8bn as of June 17, 2026.

What is the P/E ratio for Teleflex stock?

The price to earnings (P/E) ratio for Teleflex (TFX) stock is 0 as of June 17, 2026.

Does Teleflex stock pay dividends?

Yes, the Teleflex (TFX) stock pays dividends to shareholders. As of June 17, 2026, the dividend rate is $1.02 and the yield is 1.05%. Teleflex has a payout ratio of 0% on a trailing twelve-month basis.

When is the next Teleflex dividend payment date?

The next Teleflex (TFX) dividend payment is scheduled for June 30, 2026.

What is the beta indicator for Teleflex?

Teleflex (TFX) has a beta rating of 0.81. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy Teleflex stock | $TFX Share Price

About Teleflex

Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.

Ticker

$TFX

Sector

Health

Primary listing

NYSE

Employees

15,500

Headquarters

Wayne, United States

Website

www.teleflex.com

Teleflex Metrics

BasicAdvanced

$5.8bn

-

-$22.80

0.81

$1.02

1.05%

What the Analysts think about Teleflex

Analyst ratings (Buy, Hold, Sell) for Teleflex stock.

Bulls say / Bears say

Private equity firms CVC Capital Partners and GTCR have made a joint proposal to take Teleflex private, indicating strong strategic interest and suggesting that the company’s core assets may be undervalued by the market.

In December 2025, Teleflex agreed to sell three non-core businesses for $2.03 billion, allowing it to concentrate on its critical care and hospital units, streamline its operations, and strengthen growth in its main markets.

Management plans to use roughly $1.8 billion of the divestiture proceeds for a $1 billion share buyback and to pay down $800 million in debt, reflecting a disciplined approach to capital return and aiming to increase shareholder value.

Teleflex’s fourth quarter 2025 results fell well below expectations, with revenue at $569 million compared to the consensus of $919.3 million, and adjusted EPS of $1.91 missing the $3.73 estimate. Shares dropped 8.8% in premarket trading.

The company provided guidance for fiscal 2026 with adjusted earnings between $6.25 and $6.55 per share, far below the $14.28 consensus, raising concerns about its future profitability.

Teleflex initiated a Class I recall of its Hudson RCI Sheridan endotracheal tubes following reports of four patient deaths caused by device disconnections, putting the company under regulatory scrutiny and exposing it to possible legal risks.

Data summarised monthly by Lightyear AI. Last updated on 22 May 2026.

Teleflex Financial Performance

Revenues and expenses

QuarterlyAnnual

Q3 24

QoQ growth

Revenue

$37bn

-39.75%

Net income

$45bn

107.52%

Profit margin

37.65%

6.78%

Teleflex Earnings Performance

Company profitability

QuarterlyAnnual

Q4 23

Q1 24

Q2 24

Q3 24

Q4 24

Actual

$3.69

$2.85

$2.45

$2.42

-

Expected

$3.55

$2.61

$2.05

$2.31

$3.94

Surprise

3.94%

9.20%

19.51%

4.63%

-

Teleflex News

AllArticlesVideos

Four‑Year BIOMAG™-I Study Results Presented at EuroPCR Confirm Long‑Term Safety and Sustained Performance of the Freesolve™ Resorbable Magnesium Scaffold (DREAMS 3G)

Business Wire·1 week ago

Teleflex Incorporated Announces Pricing of $500 Million Senior Notes Offering

Business Wire·2 weeks ago

Teleflex Incorporated Announces Private Offering of $500 Million of Senior Notes Due 2032

Business Wire·2 weeks ago

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.

Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.